Li Kang Biomedical Co., Ltd.

NT$31.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6242Consumer Disc
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 2.28%
Div yield 6.35%
ROE 9.12%
Travel Services
Beta (5Y) (0.12)
PE TTM 13.23
TSR TTM (15.73%)
Mkt cap NT$1.002B
ROIC 8.81%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$36
13.75%
(95.32%)
Hold 7|11|4|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.76
0.82
0.86
0.85
8.24%
18.81%
22.61%
13.78%
RevenueNT$M
77.09
76.03
75.02
75.64
10.11%
7.75%
3.03%
2.30%
Peers (US$30.26M)
Cap (US$)
PE
36.67M
16.42x
29.05M
—
Capital
TTM
5Y
10Y
Leveragex
1.927
(0.582)
(0.491)
EBIT/Intx
7.626
0.152
0.177
Own earn%
(12.39)
222.44
180.35
Sh yield%
33.60
15.56
19.74
Owners
Insiders/Inst%
7.80
65.20
Short interest%
3.26
SBC / revenue%
0.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
2–5
$1 testx
−0.3
Incr. ROIC%
3